Does anyone know where we stand currently with our peptides as far as use in human trials. If i understand correctly we have been comparing our product to the apparent gold standard "TAT" peptides? I assume TAT peptides are currently already in use in approved medications. I wonder do we need to go through clinical trials with our cpp alone or will it be tested as a complete package with cpp and conjugated drug attached when the time comes?
Does anyone know where we stand currently with our peptides as...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
0.020(1.59%) |
Mkt cap ! $743.6M | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.28 | $1.24 | $46.67K | 37.07K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15857 | $1.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |